BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 23764479)

  • 21. Recent advances and current issues in single-cell sequencing of tumors.
    Sun HJ; Chen J; Ni B; Yang X; Wu YZ
    Cancer Lett; 2015 Aug; 365(1):1-10. PubMed ID: 26003306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion genes and their discovery using high throughput sequencing.
    Annala MJ; Parker BC; Zhang W; Nykter M
    Cancer Lett; 2013 Nov; 340(2):192-200. PubMed ID: 23376639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?
    Ross JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):837-8. PubMed ID: 16255622
    [No Abstract]   [Full Text] [Related]  

  • 24. The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.
    Cloonan N; Waddell N; Grimmond SM
    IDrugs; 2010 Nov; 13(11):778-81. PubMed ID: 21046525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efforts aimed at reducing noise, data overload in microarrays.
    Tuma RS
    J Natl Cancer Inst; 2005 Aug; 97(16):1173-5. PubMed ID: 16106018
    [No Abstract]   [Full Text] [Related]  

  • 27. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
    Arnedos M; Vielh P; Soria JC; Andre F
    J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From next-generation sequencing to nanopore sequencing technology: paving the way to personalized genomic medicine.
    Ku CS; Roukos DH
    Expert Rev Med Devices; 2013 Jan; 10(1):1-6. PubMed ID: 23278216
    [No Abstract]   [Full Text] [Related]  

  • 31. [Predictive medicine - clinical genetics 2010].
    Blum HE
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1334-8. PubMed ID: 20556694
    [No Abstract]   [Full Text] [Related]  

  • 32. More Pitfalls Related to Next-generation Sequencing (NGS).
    Sorscher S
    Am J Clin Oncol; 2016 Aug; 39(4):424. PubMed ID: 27465427
    [No Abstract]   [Full Text] [Related]  

  • 33. Initial experience with genomic profiling of heavily pretreated breast cancers.
    Staren ED; Braun D; Tan B; Gupta D; Kim S; Kramer K; Markman M
    Ann Surg Oncol; 2014 Oct; 21(10):3216-22. PubMed ID: 25047475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next-generation sequencing and potential applications in fungal genomics.
    Sanmiguel P
    Methods Mol Biol; 2011; 722():51-60. PubMed ID: 21590412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer. Developing molecular biomarkers for cancer.
    Ransohoff DF
    Science; 2003 Mar; 299(5613):1679-80. PubMed ID: 12637728
    [No Abstract]   [Full Text] [Related]  

  • 36. Microarray: an instrument for cancer surgeons of the future?
    Broadhead ML; Clark JC; Dass CR; Choong PF
    ANZ J Surg; 2010; 80(7-8):531-6. PubMed ID: 20795968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine.
    Butler KS; Young MY; Li Z; Elespuru RK; Wood SC
    Regul Toxicol Pharmacol; 2016 Feb; 74():178-86. PubMed ID: 26387931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular profiling of renal cancer: the journey to clinical application.
    Ribal MJ
    Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486
    [No Abstract]   [Full Text] [Related]  

  • 39. Epistatic interactions and drug response.
    Weigelt B; Reis-Filho JS
    J Pathol; 2014 Jan; 232(2):255-63. PubMed ID: 24105606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microarrays in cancer: research and applications.
    Ochs MF; Godwin AK
    Biotechniques; 2003 Mar; Suppl():4-15. PubMed ID: 12664679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.